Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    DB expects EU pharma 'malaise' to continue amid US headwinds

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    08/07/2025 10:16
    ** Deutsche Bank stays cautious about the European pharmaceutical sector, expecting "the sector malaise" to persist due to political headwinds in the U.S.

** It says that "things have got a little slipperier" for the sector's outlook, though there may also be opportunities

** It adds that while the pan-European index .STOXX is up YTD, the pharma sub-sector .SXDP has fallen, with large pharma down by mid-single digits

** If excluding Novo Nordisk NOVOb.CO, the pharma sector performance would have been slightly better, it says

** Novo Nordisk's shares have fallen 29% YTD


    COMPANYRATINGOLD RATINGPTOLD PT
    Argenx ARGX.BRBuyHoldEUR 550EUR 525
    Swedish Orphan Biovitrum SOBIV.STHoldSellSEK 285-
    Curevac CVAC.O5CV.DEHold-$5.46$3.50
    Roche ROG.SSell-CHF 235CHF 250
    Sandoz SDZ.SBuy-CHF 48CHF 42
    Zealand Pharma ZELA.COHold-DKK 400DKK 485
    

 (Reporting by Marta Serafinko in Gdansk)

 ((Marta.Serafinko@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Zealand Pharma A/S

    See all news